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"Tolerization" of Human T-Helper Cell Clones by Chronic 
Exposure to Alloantigen: Culture Conditions Dictate 
Autocrine Proliferative Status but not Acquisition of 
Cytotoxic Potential and Suppressor-Induction Capacity 
G . Pawelec, T. Brocker, F. W. Busch, H . J. Bühring, N . Fernandez, 1 E . M . Schneider, and P. Wernet 2 
Immunology Laboratory, Medizinische Kl in ik , D-7400 Tübingen, Federal Republic of Germany 
Precis 
Induction of clonal anergy in T-helper (Th) cells may 
have a role in regulating immune responses. A model 
System for studying Th cell tolerization at the clonal 
level i n vitro could be useful for investigating the 
mechanisms involved. Accordingly, alloreactive 
helper cells were maintained in culture with inter-
leukin 2 (IL 2) by intermittent Stimulation with spe-
cific antigen. Regardless of the frequency of antigen 
Stimulation, clones of age <ca. 35 population dou-
blings (PD) were found to undergo antigen-specific 
autocrine clonal expansion in the absence of exoge-
nous IL 2. Such young clones (designated as phase I) 
could therefore not be "tolerized" by frequent expo-
sure to antigen. In contrast, most clones of age >ca. 
35 PD could be tolerized by frequent exposure to an-
tigen (designated as phase II clones). Their autocrine 
proliferation was then blocked, although they still 
recognized antigen specifically as shown by their re-
tained ability to secrete interferon-gamma (IFN-7) 
and granulocyte-macrophage colony stimulating 
factor (GM-CSF). The mechanism of response 
failure involved both an inability to upregulate IL 2 
receptors in the absence of exogenous IL 2, as well as 
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an inability to secrete IL 2. These defects were not 
overcome by Stimulation with mitogens or calcium 
ionophore and phorbol esther in place of alloantigen. 
T-cell receptor a, ß, and 7-chain gene rearrange-
ments remained identical in phase I and phase II 
clones. Tolerization of phase II clones could be 
avoided by increasing the period between antigen ex-
posures. Despite this, whether or not phase II cells 
were capable of autocrine proliferation, they were 
found to have acquired the novel function of inducing 
suppressive activity in fresh lymphocytes. Sup-
pressor-induction was blocked by the broadly reac-
tive M H C class II-specific monoclonal antibody 
(moAb) T Ü 3 9 , but not by moAb preferentially 
reacting only with HLA-DR, DQ, or DP. Sequential 
immunoprecipitation on T-cell clones showed the 
presence of a putative non-DR, DQ, DP, TÜ39+ mol-
ecule on phase II clones. However, this molecule was 
also found on phase I clones. The nature of the 
TÜ39-blockable suppressor-inducing determinant 
present on phase II but not on (most) phase I clones 
thus remains to be clarified. In addition to sup-
pressor-induction activity, phase II clones also ac-
quired lytic potential as measured in a lectin approx-
imation system. Cytotoxic (CTX) potential was also 
not influenced by the frequency of antigenic Stimula-
tion and could be viewed as a constitutive modulation 
of clonal function. 
These results demonstrate age-related alterations 
in the functional Status of monoclonal Th cell popula-
tions in terms of their tolerizability for autocrine pro-
liferation (which depends on the frequency of antigen 
Stimulation in culture), and their acquisition of sup-
pressor-inducer capacity and CTX potential (which 
appear to be constitutive properties of these clones). 
J Mol Cell Immunol (1988) 4:21-34 © Springer-Verlag New York Inc. 1988 
Similar modulations of function i n vivo, should they 
occur, may be of importance in the establishment 
and maintenance of tolerant states. 
Introduction 
Normal human T lymphocytes cultured with stimu-
lating antigen and interleukin 2 (IL 2) for extended 
periods have been reported to retain specificity and 
function [1-3]. However, numerous studies have 
explored alterations in functional Status of T cell 
clones (TCC) during continued culture [1-7]. It has 
also been reported that "tolerization" of T C C may 
occur after treatment either with high doses of an-
tigen and/or inappropriately presented antigen, 
which results in apparently permanent nonreac-
tivity [8-10] or with high doses of I L 2, the effects 
of which may be temporary [11]. 
In the present article, we examine an alteration in 
the functional Status of human alloreactive T h - T C C 
which appears to be a constitutive property of the 
clones, but which is superimposed on a second 
functional modulation dictated by culture condi-
tions. We previously reported that the majority of 
T h - T C C lost their autocrine proliferative capacity 
after ca. 35 P D [12]. This appeared to be a perma-
nently altered State because none was found to re-
gain autocrine proliferation on continued culture 
with antigen and I L 2. Moreover, these T C C were 
found to have acquired suppressive activity for 
lymphocyte proliferative responses and the ability 
to induce suppressive activity in normal peripheral 
blood mononuclear cells ( P B M C ) . Cell contact and 
proliferation of responding cells was required for 
the induction of suppressive activity and this could 
be inhibited by certain broadly reactive M H C class 
II-specific monoclonal antibodies (moAb) [12]. The 
induced suppressive cells were capable of limited 
autocrine proliferation and this Stimulation was 
blocked only by the same broadly reactive class II 
moAb [13]. These stimulatory determinants were 
operationally designated " D Y " [14]. 
The studies alluded to above were all performed 
with T C C which were propagated by weekly Stimu-
lation with specific alloantigen, and given crude I L 
2 preparations two or three times per week. In 
order to investigate the reasons for modulation of 
function of alloreactive T C C under conditions of 
chronic antigenic Stimulation, we cultured T C C 
with antigen and purified I L 2 preparations and ex-
amined the expression of T-cell antigen receptor 
(TCR) using moAb, as well as functional Status in 
readout Systems not involving clonal expansion 
(secretion of G M - C S F and IFN-7), C T X and sup-
pressor-inducer activity. In addition, alterations in 
T C R a, ß , and 7 chain gene rearrangement profiles 
using Southern blotting techniques were sought. 
The results reported here suggest that functional 
modulation within T h - T C C in the direction of sup-
pressor-induction and C T X is a constitutive prop-
erty of these aging cells, whereas autocrine clonal 
expansion is environmentally regulated by the 
availability of specific antigen during propagation. 
Results and Discussion 
Alterations i n autocrine p r o l i f e r a t i v e Status o f 
alloreactive T C C under different conditions o f 
antigen exposure 
Taking clones 7 d after Stimulation and cryopre-
served at different ages during their regulär mainte-
nance cycle (weekly antigen Stimulation), it was 
confirmed that alloreactive phase I T C C had lost 
autocrine proliferative capacity by ca. 35 P D (Table 
1). This correlated with a reduced ability to upregu-
late I L 2 receptors (IL 2R), as detected with moAb 
TÜ69, in the absence of exogenous I L 2 (Fig. 1). 
This was not a result of a shift in the kinetics of the 
response (data not shown). Even when such phase 
II cells were restimulated in the presence of exoge-
nous I L 2, levels of 3 H - T d R incorporation were re-
duced compared to phase I cells (Table 1), and this 
was reflected in a slowdown of growth in mainte-
nance culture for most clones (data not shown). 
However, by increasing the period between expo-
sure to antigen from 5-7 d to 9-12 d, before testing 
autocrine proliferation, T C C were shown to retain 
proliferative Status beyond 35 P D (Table 1). If 
maintained for longer than two weeks in the ab-
sence of antigen, the T C C died off. B y restimu-
lating with antigen every 10 d, autocrine prolifera-
tive capacity could be retained for the entire finite 
lifespan of the T C C (ca. 55-65 P D for most clones). 
The defective response of phase II cells was fur-
ther investigated using stimulating agents which 
bypassed activation Signals mediated by the T C R -
CD3 complex. It was found that phase II cells had 
also lost the ability to respond to phorbol esther 
(TPA) and calcium ionophore (ionomycin, Io). This 
is illustrated for clone 257-6 in Figure 2. Although 
phase I cells 5 d after antigen Stimulation responded 
well to antigen alone or to 10 to 200 ng/ml T P A 
combined with 500 to 1000 ng/ml Io (but to neither 
agent alone) in the absence of antigen (data not 
shown), phase II cells 5 d after restimulation re-
sponded neither to antigen nor to combinations of 
TPA together with Io (Fig. 2). However, the same 
phase II cell culture 9 or 12 d after antigen Stimula-
tion regained autocrine proliferative capacity when 
stimulated by either antigen or TPA + Io. 
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Table 1. Autocrine proliferative responses of phase I and II Th-TCC at different times after antigen Stimulation. 
Medium + 
Clone Medium Stimulator3 IL 2 Spec. stim. Spec. Stirn. + IL 2 
248-3 Phase I 253 101b 6728 769 42744 5108 67285 ± 5490 
250-7 (<30PD) 148 74 10334 ± 993 28935 ± 2604 55629 ± 6322 
257-6 7 d after 632 ± 228 7335 830 39831 ± 3807 70253 ± 7236 
260-4 antigen 555 ± 238 5639 879 46384 ± 4288 52385 ± 6000 
248-3 Phase II 628 ± 242 3207 1141 935 307 4012 ± 938 
250-7 (35-40PD) 527 ± 110 4529 ± 2440 833 ± 256 5630 ± 605 
257-6 7 d after 1322 ± 345 2999 ± 349 1735 143 7634 ± 962 
260-4 antigen 400 211 2566 273 534 •± 138 3877 ± 633 
248-3 Phase II 423 ± 42 3343 590 39653 •+ 4122 58354 ± 4834 
250-7 (35-40PD) 356 148 4547 265 23042 1924 36278 ± 4024 
257-6 12 d after 893 213 3345 563 41562 ± 3908 54279 ± 6133 
260-4 antigen 635 264 2675 632 59386 ± 5281 63900 ± 7072 
a Stimulating agents were 20 U/ml IL 2 and/or 2.5 x 104/well specific alloantigen-positive irradiated B - L C L cells, on 1 x 104 T C C . 
Culture duration, 66 h; altering kinetics did not change pattern of results (data not shown). 
b Data given as mean C P M of triplicate cultures ± SDM. 
700 
200 
ZOG 
Unstimulated Stimulated Unstimulated Stimulated 
Fig. 1. Expression of IL 2R on Th-TCC after antigen Stimulation. Th-TCC 248-3 (A), 250-7 (B) and 257-6, (C) were taken from mainte-
nance culture 7 d after antigen Stimulation (unstimulated), or rechallenged with specific K R - L C L for 48 h (stimulated) prior to assessing 
IL 2R expression using moAB TÜ69 in linear FACS. The left-hand side of the figure shows marked upregulation of IL 2R by phase I 
cells, whereas the right-hand side shows only marginal upregulation of IL 2R by phase II cells. 
Lymphokine production by phase I and II T C C 
A s shown above, phase II clones 7 d after exposure 
to antigen were no longer capable of autocrine pro-
liferation. This may have been due entirely to their 
inability to upregulate I L 2R in the absence of ex-
ogenous I L 2. However, it had previously been es-
tablished that they were also defective in I L 2 se-
cretion [12], It was therefore asked whether secre-
tion of lymphokines thought to be unrelated to the 
23 
D a y s wi thout a n t i g e n pr ior Jo r e s t i m u l a t i o n : 
5d 9d 12d 
l o n o m y c i n in n g / m l 
Fig. 2. Autocrine proliferative responses of phase II cells at 
various times after antigen Stimulation. Phase II cells from clone 
257-6 were cultured with specific alloantigen and IL 2 for 5, 9 
and 12 d prior to harvest and Stimulation by a variety of agents. 
The Upper part of the figure shows responses to titrated doses of 
Io and TPA in the absence of specific antigen, while the bottom 
part of the figure shows the same experiment performed in the 
presence of specific alloantigen. Io was titrated as shown, TPA 
as follows: • , 200; O, 100; 10; and • , 0 ng/ml. 
proliferative requirements of the cloned cells them-
selves was coordinately downregulated or whether 
antigen-specific reactivity of phase II clones could 
still be demonstrated. For this purpose, secretion of 
G M - C S F and I F N - 7 w a s studied. Factors sup-
porting G M colony formation from normal human 
B M cel ls were found to be secreted in large 
amounts by phase I clones after specific Stimulation 
but not after third-party Stimulation (Table 2). 
Phase II clones retained this capacity, showing that 
antigen-specific effects were still measurable in 
these cells. Thus, the T C R - C D 3 complex was still 
capable of delivering activation signals to the cells. 
A similar antigen-specific Stimulation of G M - C S F 
secretion by phase I clones and its retention by 
phase II clones has also been observed in nine ad-
ditional clones (data not shown). Furthermore, a 
similar result was obtained for the secretion of 
IFN-7, another lymphokine thought not to be in-
volved in the clonal expansion of the T C C them-
selves. Phase II cells retained the ability to secrete 
this lymphokine (Table 3). These results appear to 
bear some similarity to a recent murine model in 
which T cells may be 4 ' tolerized' ' by exposing them 
to antigen on l-ethyl-3-(3-dimethylamino-propyl) 
carbodiimide-treated antigen presenting cells. Such 
T cells failed to secrete I L 2 but retained their 
ability to secrete IFN -7 and I L 3 [15]. 
M o d u l a t i o n of f u n c t i o n i n T h - T C C : 
Cytotoxic Status 
The previous results suggested that phase II Th-
T C C 5-7 d after antigen Stimulation had retained 
functional, antigen-specific T C R but were unable to 
undergo autocrine clonal expansion due to a block 
at a stage distal to TCR-CD3-mediated signalling. It 
was therefore investigated whether other changes 
in their functional Status had occurred in the phase 
II State. The C T X activity of these cells was tested 
since we had previously demonstrated acquisition 
of a weak MHC-unrestricted " N K - l i k e " C T X by 
the majority of aged clones cultured with T cell-
conditioned medium as a crude source of I L 2 [12]. 
Others had also reported the acquisition of allospe-
cific C T X by T C C [16]. However , none of the 
present clones in phase I or phase II were C T X on 
either allospecific targets or on highly NK-suscep-
tible K562 targets in a 4 h 5 1Cr-release assay (Table 
4). Nonetheless, all the phase II, but not the phase 
I, cells mediated lectin (PHA)-dependent C T X on 
K562, suggesting that the acquisition of C T X ma-
chinery may be a general characteristic of phase II 
cells 7 d after antigen Stimulation. Moreover, phase 
II cells 12 d after antigen Stimulation, which had 
regained autocrine proliferative capacity, nonethe-
less retained their acquired lectin-dependent C T X 
(data not shown). 
M o d u l a t i o n of f u n c t i o n i n T h - T C C : Suppressive 
activity and expression o f ' D Y " 
Phase II T C C were found to induce suppressive ac-
tivity in normal P B M C . The induction of suppres-
sive activity was blocked by moAb TÜ39 but not 
by TÜ22 (DQ), T Ü 3 4 (DR), or B7/21 (DP) . The 
TÜ39-inhibitable suppressor-inducer Status of the 
T C C correlated with their expression of t l D Y " - d e -
terminants detected by primed lymphocyte typing 
[13]. Thus, only phase II, but not phase I, cells 
were functionally " D Y ^ - p o s i t i v e , as shown by 
their s t imula tory capac i ty on 4 ' D Y " - r e a c t i v e 
clones. Furthermore, Figure 3 shows that phase II 
cells which had regained autocrine proliferative ca-
pacity >9 d after antigen Stimulation retained their 
acquired abil i ty to induce suppressive activity. 
Thus, phase I T C C 5 d after antigen Stimulation did 
not induce suppressive activity in normal P B M C , 
but phase II cells did induce suppression, regard-
less of whether they were tested 5, 9, or 12 d after 
antigen Stimulation (Fig. 3). In these respects, ac-
quisition of suppressor-inducer capacity and C T X 
appear to be preprogrammed events which occur 
independently of environmentally determined alter-
ations in autocrine proliferative Status. 
M H C class II expression by phase I and II T h - T C C 
The induction of suppression by phase II clones 
24 
Table 2. Specificity of Stimulation for G M - C S F secretion by phase 1 and II Th-TCC 
248-3 250-7 257-6 260-4 
Stirn.3 I II I II I II I II 
KR5 96 ± 5b 50 ± 3 74 ± 6 63 ± 4 93 ± 7 76 ± 3 75 3 49 ± 4 
WH5 94 ± 18c 95 16 98 ± 15 95 16 125 ± 17 92 ± 22 98 ± 11 96 ± 3 
WK1 25 ± 6 12 ± 3 2 ± 1 9 ± 5 1 ± 1 0 3 ± 2 0 
GM2 20 5 1 ± 1 37 ± 3 0 13 ± 1 0 9 3 4 ± 4 
Medium 4 1 0 12 ± 3 2 ± 1 0 0 5 ± 3 3 ± 2 
a Stimulators (Stirn.) were B - L C L from the donor of the original sensitising cells, KR5 (HLA-DR5), from WH5 (DR5), WK1 (DR1), or 
GM2 (DR2), or no stimulator (Medium). 
b % of maximal colony formation supported by 10% H P C M (a plateau concentration in these experiments). 
c % of colony formation ± SDM (mean of at least 3 experiments) supported by supernatant of Th-TCC stimulated with specific antigen 
(KR5 B - L C L ) . The results shown are for 10% Th-TCC supernatant harvested 48 h after Stimulation. 80 Gy-irradiated B - L C L alone have 
not been observed to produce GM-CSF. Titrating these from 20-2% in initial experiments, or altering kinetics of production, did not 
significantly alter the pattern of the result. 
Table 3. Secretion of IFN-7 by phase I and II Th-TCC 
250-7 257-6 260-4 
Stirn. I II I II I II 
KR5 >1000a >1000 >1000 >1000 >1000 >1000 
WH5 nt 420 nt 304 nt 728 
WK1 nt <I5 nt <15 nt <15 
GM2 nt <15 nt <15 nt <15 
Medium nt <15 nt <15 nt <15 
a IFN-7 content in U/ml estimated from duplicate determina-
tions by IRMA. T C C supernatants were harvested at 48 h after 
Stimulation as in Table 2. Controls of B - L C L alone were consis-
tently negative. The pattern of IFN-7 secretion at 96 h was es-
sentially identical, although titers were commonly lower than at 
48 h. 
could be blocked by broadly reactive class II moAb 
TÜ39 but not by anti-DR, D Q , or D P moAb [12, 
17]. Immunoprecipitat ion experiments in which 
D R , D Q , and D P molecules were sequentially de-
pleted from lysates of surface 1 2 5 I labeled B - or T-
cell lines demonstrated the presence of putative 
novel D R , D Q , D P " TÜ39 + class Il-like molecules 
[18]. These were therefore considered to be candi-
dates for the structures carrying functionally de-
fined "DY"-suppressor-inducer determinants. A c -
cordingly, phase I and II T C C were subjected to 
this type of analysis. Figure 4 shows that lysates of 
a phase II T C C do indeed contain such candidate 
" D Y " molecules. However, the figure also shows 
that the same T C C studied in phase I contains this 
molecule as well . Preliminary quantification experi-
ments on two clones suggest that the absolute 
quantity of " D Y " candidate molecules on phase II 
cells is greater than on phase I cells (data not 
shown). If this is confirmed in further experiments, 
then a quantitative increase of " D Y " molecules on 
Table 4. C T X activity of phase I and II Th-TCC 
Clone Phase3 K562 K562 + PHA Spec. L C L 
248-3 1 <0.1 1.3 <0.1 
II <0.1 523 <0.1 
250-7 I <0.1 0.9 <0.1 
II 3.8 738 0.5 
257-6 I <0.1 <0.1 <0.1 
II 1.1 489 6.9 
260-4 I 0.4 3.9 <0.1 
II 5.6 872 3.7 
290-2 NK-like b 972 4518 <0.1 
281-17 C T L C <0.I 1719 929 
a Phase I and II Th-TCC were tested 7 d after antigen Stimulation 
at titrated effector:target cell ratios, and data are given as lytic 
units (25% lysis) per 107 effector cells on 4000 targets. 
b Clone 290-2 is a C D 3 + C D 4 ± C D 8 - Leu l9 + cell which lyses 
only NK-susceptible target cells (Pawelec et al., manuscript 
submitted for publication). 
c Clone 281-17 is a CD3+ CD4" C D 8 + Leul9" allospecific C T X 
clone (Pawelec et al., unpublished results). 
phase II cells might explain their functional D Y -
positivity. 
T C R gene rearrangements i n phase I 
and II T h - T C C 
D N A was isolated from phase I and phase II Th-
T C C , and from subclones with or without autocrine 
proliferative capacity. The first experiments were 
limited to investigation of T C R ß-chain (and 7-
chain) gene rearrangements. The Southern blots 
clearly showed conservation of monoclonally rear-
ranged bands in T C C and subclones, regardless of 
their age or functional Status [13]. These results, 
which were obtained in all T h - T C C tested thus far 
(n = 6) are consistent with a lack of alteration of 
the T C R in phase II cells. Alterations in rearrange-
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Fig. 3. Ability of phase II Th-TCC to induce suppressive ac-
tivity. T h - T C C were irradiated and mixed 1:20 with normal 
P B M C and cultured for 3 d in medium containing human serum 
but no IL 2. These cells were then harvested, irradiated and ti-
trated into M L C between the clone donor (•) or an allogeneic 
donor (O) and an irradiated PBMC pool, at the ratio shown (re-
sponding cells per added cell). This experiment was performed 
with cells from clone 257-6 in phase I, 5 d after antigen Stimula-
tion and in phase II, 5, 9, and 12 d after antigen Stimulation, as 
shown. 
ments of a chain genes in phase II was rendered 
unlikely by the finding that clone 260-4, which was 
the only informative clone of 14 tested, demon-
strated the same rearranged band in phase II as in 
phase I (Fig. 5). In other respects this clone be-
haved identically to the remaining clones, including 
its retention of antigen-specific G M - C S F secretion 
capacity. Therefore, altered functions in phase II 
compared to phase I T C C are not associated with 
alterations in a-chain gene rearrangements. 
Summary 
Human Th clones maintained under conditions of 
chronic antigenic Stimulation lost autocrine prolif-
erative capacity and acquired lytic potential and 
suppressor-induction capacity. The former but not 
the latter changes could be modulated by culture 
conditions: namely, decreasing the frequency of ex-
posure to antigen resulted in retention of autocrine 
proliferative capacity, but did not prevent the other 
functional alterations in the clones. Specific antigen 
recognition by the cells was, however, maintained 
in all functional states, as reflected by antigen stim-
ulated GM-CSF and IFN-7 release. Aging cloned 
cells therefore appear to be committed to modifying 
their immunomodulatory activity while maintaining 
their antigenic specificity. 
Interpretation 
A loss of allostimulated autocrine proliferative ca-
pacity occurring after extended culture of human 
helper T-cell clones has previously been reported 
by ourselves [12] and others [7, 19, 20]. We noted 
that the 90% of alloreactive P L T clones which lost 
autocrine proliferative capacity after a period in 
culture acquired suppressive activity for responses 
in M L C [12, 13]. Suppression was associated with 
an acquired suppressor-inducer function which 
could be inhibited by the M H C class II-specific 
moAb TÜ39 [12], or by the I L 2R-specific moAb 
TÜ69 [17]. This suggested that cell:cell contact in-
volving M H C products, and I L 2-driven prolifera-
tion of the stimulated cells was necessary for the 
induction of suppressive activity. Suppression was 
not caused by I L 2 absorption, and as far as could 
be established, was not associated with de novo 
contamination with mycoplasma or acquired non-
specific C T X [12]. 
Such modulations in the function of T h - T C C are 
consistent with the idea that a strict regulation of 
helper activity exists even within monoclonal popu-
lations, as has been previously hypothesised [21]. 
L i m i t i n g d i lu t ion and subcloning experiments 
which showed that the frequency of proliferative 
cells within monoclonal populations decreased with 
age, support this conclusion by suggesting the gen-
eration of nonreactive variants [13]. However, lack 
of autocrine proliferation by phase II cells was not 
simply due to the presence of a lower frequency of 
potentially reactive cells, since an extended re-
stimulation kinetic did not allow a response to be 
visualized. Such phase II cells also failed to re-
spond to stimulating agents (TPA 4- Io) which by-
pass T C R - C D 3 signalling (Fig. 2). Failure to prolif-
erate was caused by a reduced ability to upregulate 
I L 2R after Stimulation in the absence of exogenous 
I L 2 (Fig. 1), as well as an inability to secrete I L 2 
[12]. 
This loss of autocrine proliferative capacity in 
T h - T C C could be manipulated by altering culture 
conditions. When clones were cultured for 9-12 d 
without antigen Stimulation, proliferative ability 
was retained until almost the end of the lifespan of 
the clones. This presumably reflects a more ex-
tended refractory period following antigen Stimula-
tion for phase II compared to phase I cells. The na-
ture of this transient post-recognition block to pro-
liferation is presently unknown. Fluctuations in the 
level of expression of T C R - C D 3 complexes did not 
seem responsible because a) phase II cells ex-
pressed the same density of CD3 and WT31-reac-
tive antigens as phase I cells [13], and b) stimulating 
agents which bypassed the C D 3 - T C R complex also 
failed to stimulate phase II cells which had not been 
"starved" of antigen. That this block was indeed 
post-recognitive was shown by retention of an-
tigen-specifically stimulated release of G M - C S F 
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Fig. 4. Expression of " D Y " molecules by phase I and II Th-TCC. Two million cell equivalents of 125I-lactoperoxidase surface labeled 
cells from Th clone 257-12 in phase I (upper panel) or phase II (lower panel) were subjected to sequential immunoprecipitation with class 
II-specific moAb followed by SDS-PAGE: (upper panel) L243 (DR), lanes A - E and SACI-RAM alone lanes F , G: TÜ22 (DQ) lanes 
H - K and SACI-RAM alone lanes L , M ; B7/21 (DP) lanes N - Q and SACI-RAM alone lanes R, S; and finally, TÜ39 ("DY"), lane T; 
(lower panel) L243 (DR), lanes A - D and SACI-RAM alone lanes E , F ; TÜ22 (DQ) lanes G - I and SACI-RAM alone lanes J , K ; B7/21 
(DP), lanes L - N and SACI-RAM alone lanes O, P; and finally, TÜ39 ("DY"), lane Q. Lane R shows molecular weight markers. 
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Fig. 5. Rearrangement of TCR a chain genes in phase I and II Th-TCC. D N A of Th-TCC in phase I and II was digested with Bam HI or 
Xho I as shown, and blotted with genomic TCR a chain probe D14S7c. Germ-line fragments of 3.5 and 1.8 kb for Bam HI and 20 kb for 
Xho I are shown from B - L C L (JR-, GP-, and D B - L C L ) . Sizes of restriction fragments were determined by co-electrophoresis of Hind 
III-digested phage-7 D N A (lane M), fragments of which were labelled by nick-translation and hybridised on the same filter. 
and IFN -7 , implying that the T C R complex still 
transduced positive Signals but that lymphokine se-
cretion was noncoordinately regulated. 
In contrast to the above Situation for autocrine 
proliferation, phase II cells acquired suppressor-in-
ducer capacity and lectin-dependent C T X activity 
apparently independently of environmental influ-
ences. In general, T h - T C C began to show sup-
pressor-inducer activity concordantly with their 
loss of autocrine proliferative capacity [12]. Sup-
pressive activity was positively correlated with the 
presence of lymphocyte stimulatory determinants 
designated " D Y " [14, 22] on these clones [13]. 
Thus, nonsuppressive phase I clones and subclones 
were unable to stimulate 4 l DY"-spec i f ic cellular re-
agents, but suppressive clones and subclones were 
able to do so [13]. This stimulatory capacity applied 
regardless of their proliferative Status, since al-
though antigen "starvation" allowed retention of 
autocrine proliferative capacity for extended pe-
riods, the acquisition of t 4 D Y " determinants was 
not affected by this treatment. Similarly, the acqui-
sition of lectin-dependent C T X was age-related but 
not influenced by frequency of exposure to antigen. 
The molecular nature of " D Y " is under investi-
gation. Sequential immunoprecipitation experi-
ments suggest the existence of distinct T Ü 3 9 + class 
II-like entities which are not precipitated by anti-
D R , D Q , or D P moAb [18]. Although these are 
present on phase II T h - T C C they are, however, 
also detectable on phase I T C C (Fig. 4). Several 
possible explanations may account for this Obser-
vat ion: 1) these extra molecules do not carry 
4 t D Y " , 2) of several extra molecules, only one 
carries " D Y " and this is indeed lacking on phase I 
cells, 3) the extra molecules act as restriction ele-
ments for the presentation of peptides which are 
only available on phase II cells, 4) quantitative dif-
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ferences in expression of extra molecules explain 
the functionally defined "DY"-pos i t iv i ty of phase 
II cells but l t DY"-negat iv i ty of phase I cells. Fur-
ther experimentation is required to distinguish be-
tween these, or other, possibilities. 
The mechanism of suppression has not yet been 
resolved. It does not appear to involve C T X , al-
though selective killing of stimulating cells such as 
dendritic cells cannot be formally excluded on the 
basis of the 5 1Cr-release test. Acquisition of specific 
C T X was not observed in the present clones, al-
though alloreactive and influenza virus-specific Th-
T C C have been reported to lyse such targets after 
aging in culture or treatment with high concentra-
tions of I F N - a [16, 23]. The latter was reported to 
be accompanied by alterations in the rearrangement 
of T C R a chain genes [23]. Since the Single T C C 
informative for the a chain which we studied had 
not acquired a l l o C T X activity, our failure to find al-
terations in a chain gene rearrangements may still 
be compatible with this. The reason that only germ-
line a-chain fragments were found with the D14S7c 
genomic a-chain probe in 13/14 T h - T C C was prob-
ably because their rearrangements involved J re-
gion segments upstream of the Bam H I and Xho I 
cleavage sites. 
There may conceivably be circumstances under 
which an extended clonal expansion of helper cells, 
such as employed here i n vitro, would result in the 
same k ind of functional modulation i n vivo. In 
chronic infections, after repeated blood transfu-
sions or after organ transplantation, the continued 
Stimulation of Th cells resulting in functional modu-
lation could contribute to immunodeficiency. A re-
port on defective T-cell reactivity in lepromatous 
leprosy is consistent with this concept [24]. Simi-
larly the finding that, even under therapeutic immu-
nosuppression, lymphocyte Stimulation and genera-
t ion of memory cells may s t i l l occur [25, 26] 
suggests s i m i l a r m e c h a n i s m s a l so i n o rgan 
transplantation. After allogeneic bone marrow 
transplantation, T-cell proliferative responses re-
main depressed for an extended period after appar-
ently successful reconstitution. This refractoriness 
is reflected in poor ability to upregulate the I L 2R 
and in mediocre I L 2 secretory capacity, although 
T C R function appeared normal as measured by 
C a 2 + ion influx [27]. Moreover, in a rat heart allo-
graft model , it was recently reported that C D 4 + 
cells which underwent priming in the presence of 
C s A , lost their capacity to transfer rejection ca-
pacity, but rather became suppressive [28]. This 
modula t ion of funct ion was dependent on the 
chronic presence of antigen, since alloreactivity 
was regained 8 d after removing the graft [29]. 
Under such conditions of chronic antigen Stimula-
tion, modulation of Th-cell function in the direction 
of suppression might occur in the majority of reac-
tive clones. 
Taken together, such possible i n vivo parallels to 
phase I-phase II functional modulations could con-
tribute to the establishment and maintenance of tol-
erant or immunodepressed states. 
Material and Methods 
T lymphocyte clones 
The T C C studied here were derived from different 
donors sensitized in mixed lymphocyte cultures 
( M L C ) to the same stimulating cells (homozygous 
typing cell K R O , 9W505, H L A genotype A 2 , B44, 
D R w l l , Dw5, DRw52, D Q w 3 , DPw2,4) by limiting 
dilution of alloactivated lymphocyte populations in 
the presence of I L 2 and stimulator-specific filier 
cells. Cultures with >75% lymphoblasts were se-
lected for cloning, cells were diluted in R P M I 1640 
+ 16% H S supplemented with 20 U/ml highly puri-
fied natural I L 2 (Lymphocult T-HP, Biotest Serum 
Institute, Frankfurt, F R G ) , and seeded at limiting 
dilution (<0.45 cells/well) into 1 mm-diameter cul-
ture wells of microtest plates (Greiner, Nür t ingen) , 
with 1 x 104 30 Gy-irradiated stimulator-specific 
P B M C in a total volume of 20 p l . In addition to 300 
wells seeded with <0.45 cells, 60 wells each at x 10 
and x 100 this concentration were also set up to 
confirm single hit characteristics of the limiting di-
lution titration for each experiment (r = 1.0 in the 
present experiments). Contents of positive wells 
were transferred after 6 -9 d to 7 mm-diameter flat 
bottom microtiter plate wells (Greiner, Nürt ingen, 
F R G ) in 200 \ü fresh medium with 1 x 105 Simu-
lator P B M C , and then again transferred to 16 mm-
diameter Cluster plate wells (Greiner, Nürt ingen, 
F R G ) with 2 x 105 stimulator P B M C . After 4 d, 
wells were split 1:1, adding fresh medium. After 7 
d, cultures were split to new wells at 2 x 10 5/well 
with 1 x 105 80 Gy-irradiated B - L C L derived from 
the donor of the original stimulating cells. There-
after clones were propagated by feeding with fresh 
medium every 3-4 d and restimulating with B - L C L 
every 7 d. 
The age of the clones at the time of cryopreserva-
tion was estimated as the number of P D undergone. 
Calculations for further culture of thawed cells re-
sumed at the point at which the cells had been 
frozen. Spot tests on culturing T C C for a week in 
the absence of antibiotics showed that none of the 
clones used had latent bacterial contamination. 
Mycoplasma testing was kindly performed using 
4-wk agar cultures by the Hygiene Institute of the 
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University of Tübingen. None of the clones in the 
present study showed any signs of mycoplasma 
contamination. 
The clones studied here were found in initial 
Screening assays to proliferate strongly when chal-
lenged with K R cells in the absence of I L 2 (Stimu-
lation index >100). Their alloantigenic specificity 
was defined as HLA-Dw5-associated in population 
studies, family segregation analyses, and moAb in-
hibition experiments (data not shown). The clones 
were identified as helper cells on the basis of their 
ability to stimulate Ig production from enriched B 
cell populations (F. Falcioni, unpublished results). 
Assay o f p r o l i f e r a t i v e responses 
Autocrine proliferative responses were measured 
by plating T C C (usually 1 x 104) in U-well micro-
titer plates (Greiner, Nür t ingen , F R G ) with irra-
diated P B M C or L C L (usually 1 x 105 or 2.5 x 
10 4, respectively) from H L A - t y p e d donors in R P M I 
1640 + 10% H S . In other experiments, T C C were 
stimulated by the phorbol esther tetradecanoyl-
phorbol-13-acetate (TPA, Sigma, Munich , F R G ) 
and the calcium ionophore ionomycin (Io, Calbio-
chem, San Diego, C A , U S A ) at titrated doses in the 
presence or absence of alloantigen. Incubation time 
was generally 42 or 66 h, including an 18-h pulse 
with 37 kBq /we l l tritiated thymidine ( 3 H - T d R , 
Amersham-Buchler, Braunschweig, F R G , specific 
activity 185 GBq/mmol). Incorporated radioactivity 
was quantified using ß-scintillation spectroscopy. 
In some restimulation experiments, the medium 
was supplemented with 20 U/ml H P I L 2 or recom-
binant I L 2 (the latter a kind gift of Dr M . Wrann, 
Sandoz, Vienna, lot W3/6, activity ca. 4 x 106 
units/mg protein). P H A (Gibco M , Scotland) was 
used at 1% final concentration. 
I n d u c t i o n and measurement o f suppression of 
lymphocyte p r o l i f e r a t i v e responses 
To test for suppressor-inducer capacity, irradiated 
T C C were cocul tured for 3 days with normal 
P B M C at a ratio of 1:20 in R P M I 1640 + 10% 
human serum and 60 jxg/ml tylosine (ant i -PPLO 
agent, G i b c o M , Sco t land) . These were then 
washed, irradiated, and titrated into readout M L C 
as previously described [12]. Briefly, M L C were set 
up between 5 x 104 responding P B M C and the 
same number of st imulating 20 Gy- i r radia ted 
P B M C or 30 Gy-irradiated pooled P B M C from 20 
donors, in U-wel l microtiter plates. Cells to be 
tested for suppressive activity were irradiated 20 
G y and titrated into the readout M L C , usually 
starting at a ratio of 1:1. Culture kinetic was rou-
tinely 138 h, including the 18-h pulse with 3 H - T d R 
prior to termination. Results were expressed as a 
relative response in the presence of added cloned 
cells compared to the M L C value in the absence of 
added cells. 
Assay of cytotoxicity 
Standard 4-h 5 1Cr-release assays were performed 
by coculturing labeled target cells (4000/well) with 
titrated numbers of T C C as effector cells. 2-3 x 
106 target cells (K562 and B - L C L ) were labeled 
with 9 M B q sodium 5 1chromate (specific activity 
22.2 MBq/mg chromium, Amersham-Buchler) for 
1.5 h, and the isotope release assay was of 4 h dura-
tion. P H A was used at a concentration of 1%. In 
each experiment, positive controls for natural killer 
( N K ) and allospecific C T X were included. Results 
were expressed as lytic units defined as the number 
of effector cells per 10 7 required to achieve 25% 
specific 5 1 C r release from 4000 target cells. 
Expression of I L 2R 
T-cell clones labelled with moAb were developed 
with a FITC-conjugated F(ab) 2 rabbit anti-mouse Ig 
(Dianova) as the second antibody, and analyzed on 
a F A C S IV. Dead cells exhibited a smaller forward 
light scatter intensity clearly separable from viable 
cells and were excluded from the analysis by elec-
tronic gating. The fluorescence histograms were 
area-corrected to 10,000 cells. To indicate back-
ground staining, histograms of cells labeled with 
test moAb are superimposed on those labeled with 
the nonbinding control moAb W6/32 .HK. The I L 
2R moAb employed was TÜ69. 
Lymphokine and colony stimulating factor 
production and assay 
4 x 105 rested cloned cells were restimulated in 16 
mm-diameter culture wells with 5 x 105 B - L C L 
from H L A - t y p e d donors for different periods of 
time before harvesting cell-free supernatants for 
assay. For quantification of I L 2 production, peak 
lymphokine release kinetics of 24 h applied, and I L 
2 was detected by titrating supernatants onto I L 2-
dependent T-cell lines. For studies of G M - C S F and 
IFN -7 production, clones were cultured with 10 
U/ml I L 2 as well as B - L C L . For all lymphokine 
assays, controls consisted of cloned cells or stimu-
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lator cells incubated in medium alone. IFN-7 was 
measured using an I R M A kit according to the man-
ufacturer's instructions (Celltech, Slough, U K ) . 
Factors in supernatants of T C C which facilitated 
the growth of human bone marrow G M colonies 
were assayed in the absence of the Standard source 
of G M - C S F (human placenta conditioned medium, 
H P C M ) . B M mononuclear cells (isolated on 1.077 
g/cm 3 Percoll gradients) were cultured in a Single 
layer methylcellulose System. 1 x 105 cells/ml were 
plated in 0.9% methylcellulose supplemented with 
20% prescreened fetal calf serum and 10% v/v 
cloned cell-derived or control supernatant. Tripli-
cate cultures were plated in 16 mm-diameter Cluster 
wells, and colonies (>50 cells) were enumerated on 
d 14. Initial experiments established that peak G M -
C S F occurred at 24-48 h. Titration experiments 
showed that plateau ( H P C M ) level colony forma-
tion was achieved using 10% T h - T C C supernatant. 
Sequential immunodepletion procedures 
For immunoprecipi tat ion studies, m o A b L243, 
T U 2 2 , B7/21, and TU39 were purified by Protein A 
Sepharose 4B affinity chromatography according to 
Ey et al . [30]. 
T C C were surface labeled with 1 2 5 I by the lacto-
peroxidase catalyzed method [31]. Briefly, 2 x 107 
T C C were resuspended in 0.5 ml of cold saline to 
which 18,000 k B q of carrier-free sodium 1 2 5I-iodate 
(Amersham) was added. In rapid sequence, 30 U of 
lactoperoxidase (Calbiochem, specific activity 90 
U/ml) 15 |xl of glucose oxidase (Sigma) and 75 jxl of 
glucose (Sigma, 50 mg/ml) were added, and the re-
ac t ion was s topped after 30 min by repeated 
washing in cold saline. 
Immunoprecipitation studies were performed as 
previously described [32]. Briefly, labelled cell ex-
tracts were "precleared" with 100 |xl of protein A -
bearing Staphylococcus aureus Cowan I (SACI) 
and 50 (xl of S A C I coupled to rabbit anti-mouse 
globulin ( S A C I - R A M ) . Two million cell-equivalents 
were then incubated with 1 |xg of Protein A Sepha-
rose-purified moAb at 4° for 1 h. Immunocomplexes 
were then incubated with 50 jxl S A C I - R A M to en-
sure identical binding capacity of the S A C I to the 
various moAb. The precipitates were then washed 
x 3 in lysis buffer without detergent. For sequential 
immunoprecipitat ions, the supernatant was re-
tained for serial transfer at each step to tubes con-
taining identical amounts (1 jxg) of the different 
m A b , followed by S A C I - R A M , and repetition of 
the above. A t each step, material was retained for 
gel analysis as follows: bound proteins were solubi-
l ized by boiling for 3 min in elution buffer con-
taining SDS and DTT, and visualized by electro-
phoresis on 12.5% Polyacrylamide slab gel [33] fol-
lowed by f ixing and f luorography in A m p l i f y 
(Amersham) and autoradiography on Hyper f i lm 
M P (Amersham) at - 7 0 ° . 
T-cell antigen receptor gene rearrangements 
D N A from T C C was isolated according to Standard 
procedures involving SDS-lysis, Proteinase K di-
gestion, phenol and Chloroform extraction, fo l -
lowed by ethanol precipitation. Approximately 5 jxg 
D N A of each sample were digested with the appro-
priate restriction enzyme at 5 units/|xg D N A , ac-
cording to the instructions of the manufacturer 
(Boehringer, Mannheim, F R G ) . Digested D N A was 
electrophoresed through 0.6% or 0.7% agarose 
gels, denatured by alkali , neutralized and trans-
ferred to nylon filters (Amersham). The T C R a 
chain genomic probe was a 1.5 kb Hind III frag-
ment, designated D14S7C, of the clone K40 derived 
from the breakpoint region of a (11/14) transloca-
tion leukemia [34]. This was a kind gift of Dr . D . 
Mathieu-Mahoul, Paris, and was subcloned in the 
pSP4 vector. The probe was labeled by incorpo-
rating 3 2 P d C T P (1.1 x 10 1 4 Bq/mmol, Amersham) 
using random oligonucleotide primers (Pharmacia, 
Freiburg, F R G ) and the large fragment of D N A 
Polymerase I (Klenow enzyme, Boehringer, Mann-
heim, F R G ) . The specific activity of the probe was 
approximately 1 x 10 9 cpm/|xg of insert D N A . 
Filters were hybridized in 5 x S S C (1 x S S C : 150 
m M N a C l , 15 m M Na-citrate) at 65° for 12-16 h at a 
radioactive concentration of 5 x 106 to 1 x 10 7 
cpm/ml. Final washing of the filters was in 0.1 x 
S C C & 0.1% SDS at 60-65° , which were then au-
toradiographed for 18-36 h at - 7 0 ° using intensi-
fying screens. 
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A Critique 
This paper covers two distinct topics relating to 
long-term growth of alloreactive CD4 ("helper") T 
cell clones. First, that after time, the clones require 
a rest after antigenic restimulation before they can 
again respond to alloantigen by prol iferat ion. 
Second, that after time, all such clones develop 
non-specific cytotoxicity (but not specific cytotox-
icity), and also suppress M L R . 
Questions one would like to have answered are: 
1. Does the nature of the Stimulus determine ac-
quisition of phenotype? The authors use L C L ' s , 
while in the mouse spieen cells are used, and are 
necessary to maintain growth and specificity. 
This is an obvious difference. 
2. Does E C D I treatment, or ionomycin treat-
ment, generate "Phase I I " responses of "Phase 
I " lines? 
3. What does change about phase II cells to ac-
count for the results? Is the chemistry of the re-
ceptor distinct. 
4. What are D Y antigens? This is a whole sepa-
rate story and should be removed to focus on the 
"tolerance" issue. 
Charles A . Janeway, Jr. 
A Critique 
The manuscript describes experiments on human T 
helper cell clones and their longterm behavior in 
vitro. During the course of long-term culture, the 
cells become dependent on Interleukin-2, and ac-
quire suppressive and cytotoxic function. It has 
been observed, that the frequency of antigen resti-
mulation influences the time point at which the 
clones become dependent on Interleukin-2. In con-
trast, the cells acquire suppressive and cytotoxic 
activities at time points independent of the fre-
quency of antigenic restimulation. 
The manuscript describes a careful and detailed 
study on the behavior of the cell lines, including 
cellular and molecular analyses. The study is of in-
terest for those who work with long-term in vitro 
cultures of human T lymphocytes. 
The experiments do not address the point of T 
helper cell tolerance, which the authors claim in the 
precis and at various points in the text. It is very 
unlikely that T cell undergoes 35 duplications i n 
vivo, the time point at which in this paper a fre-
quently antigen exposed T cell clone becomes " to l -
er ized." 
The Authors Respond 
Response to first critique 
Point 1) we have found essentially similar behav-
iour on the part of clones cultured on peripheral 
blood cells rather than B cell lines (this is docu-
mented in Ref. [12] of the article, / / 736:402, 1986). 
Point 2) it is not possible to maintain clonal ex-
pansion with phorbol esthers and/or calcium iono-
phores, so this question cannot be answered. 
Point 3) we do not have any data on the chem-
istry of the antigen receptor on these clones, but 
have shown in the present manuscript that it con-
tinues to function in an antigen-specific manner. I 
think that this makes it unlikely that modifications 
to the receptor itself play a part. Other changes in 
phase II cells concern increased density of class II 
molecules including the "DY"-candidate molecule 
(see Fig . 4) which we argue may be related to one 
of the functional changes observed, ie. induction of 
suppressive cells by "DY"-pos i t ive clones. 
Point 4) "DY"-determinants are an integral part 
of the "act ive" tolerance story, are not a separate 
story and should not be removed from the paper. 
Response to second critique 
The Reviewer believes that our use of the term 
"tolerance" is inappropriate, arguing that it would 
be unlikely that a T cell would undergo 35 popula-
tion doublings before the phenomena which we 
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have described i n vitro would occur i n vivo. H o w -
ever, this is purely a matter of opinion, since no 
data on this topic are extant. We would argue that 
at least under certain conditions, for example in 
chronic infections or in allograft rejection episodes, 
it is easily conceivable that this number of dou-
blings could take place. We would like to take this 
opportunity further to clarify our use of the term 
"toler izat ion." In the present manuscript, we ad-
dress the question of tolerance in an i n vitro model 
at two distinct levels, as implied by the title of the 
communication; namely that which could be desig-
nated "pass ive" and that which could be desig-
nated "ac t ive ." B y this we mean the loss of pre-
vious activities by a helper T-cell clone which can 
no longer enhance immunity (passive tolerance) 
and the acquisition of new abilities by which helper 
clones would no longer enhance immunity but 
rather actively inhibit it (active tolerance). Thus, 
we have shown that C D 4 + helper T cell clones lost 
the ability to undergo autocrine clonal expansion in 
phase II concomitant with loss of ability to secrete 
helper factors such as I L 2. In addition, we have 
since shown that such clones were also no longer 
able to produce helper factors enhancing B cell an-
tibody secretion (Pawelec et a l . , Transplantation 
Proceedings, in press). On the other hand, they ac-
quired the ability to induce suppressive cells via ac-
tive stimulatory interactions governed by deter-
minants that we have called " D Y " (Pawelec et a l . , 
J. E x p . M e d . 767:243, 1988). Hence, we suggest 
that both the lost and acquired functions could con-
tribute to the establishment and maintenance of a 
tolerant State. 
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